ZVX 55
Alternative Names: COVID-19 vaccine - Scorpius Holdings/University of Miami; ZVX-55Latest Information Update: 09 Feb 2024
At a glance
- Originator Heat Biologics; University of Miami
- Developer Scorpius Holdings; University of Miami
- Class COVID-19 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued COVID 2019 infections
Most Recent Events
- 06 Feb 2024 NightHawk Biosciences is now called Scorpius Holdings
- 29 Apr 2023 Discontinued - Preclinical for COVID-2019 infections (Prevention) in USA (unspecified route) prior to April 2023 (NightHawk Biosciences pipeline, April 2023)
- 27 Jan 2023 NightHawk Biosciences terminates its agreements with University of Miami for gp96 and TNFRSF25 platforms